A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NHC SEC filings page.
National Healthcare Corp. (NHC) reported $1.5B in revenue for fiscal year 2025, up 16.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
National HealthCare's growth is translating into faster operating profit and cash with little debt.
Between FY2024 and FY2025, revenue rose16.1% while operating income rose42.8% , showing operating leverage: more of each additional dollar reached operations. Operating cash flow then rose72.5% and free cash flow86.5% , indicating earnings quality improved alongside reported profit rather than relying mainly on non-cash accounting gains.
Long-term debt fell
Free cash flow reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of National Healthcare Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. National Healthcare Corp. scores 57/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. National Healthcare Corp. scores 76/100 on it among other operating companies.
National Healthcare Corp. held more cash than long-term debt at the end of fiscal year 2025, with $92.8M of cash against $32.5M of long-term debt. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and National Healthcare Corp. scores 83/100 among other operating companies measured the same way.
National Healthcare Corp. held $1.82 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.82. Liquidity ranks operating companies on that ratio, and National Healthcare Corp. scores 54/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. National Healthcare Corp. scores 60/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. National Healthcare Corp. scores 60/100 on it among other operating companies.
National Healthcare Corp. scores 6.17, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $3.0B against total liabilities of $451.9M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
National Healthcare Corp. passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, National Healthcare Corp. generates $1.54 in operating cash flow ($185.1M OCF vs $120.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
National Healthcare Corp. earns $20.15 in operating income for every $1 of interest expense ($128.4M vs $6.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
National Healthcare Corp. generated $408.0M in revenue in Q3 2026. This represents an increase of 6.6% from the same quarter a year earlier. It is unchanged from the prior quarter.
National Healthcare Corp.'s EBITDA was $55.2M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 32.9% from the same quarter a year earlier. Against the prior quarter it is down 8.2%.
National Healthcare Corp. reported $13.6M in net income in Q3 2026. This represents a decrease of 65.2% from the same quarter a year earlier. Against the prior quarter it is down 66.2%.
National Healthcare Corp. earned $0.85 per diluted share (EPS) in Q3 2026. This represents a decrease of 66.0% from the same quarter a year earlier. Against the prior quarter it is down 66.5%.
Cash & Balance Sheet
National Healthcare Corp. held $66.8M in cash against $478.3M in long-term debt as of Q3 2026.
National Healthcare Corp. paid $0.67 per share in dividends in Q3 2026. This represents an increase of 4.7% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q3 2026.
Margins & Returns
National Healthcare Corp.'s operating margin was 10.0% in Q3 2026, reflecting core business profitability. This is up 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.
National Healthcare Corp.'s net profit margin was 3.3% in Q3 2026, showing the share of revenue converted to profit. This is down 6.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.5 percentage points.
National Healthcare Corp.'s quarterly ROE was 1.2% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.4 percentage points.
Not reported for Q3 2026.
Capital Allocation
National Healthcare Corp. spent $1.1M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 65.1% from the same quarter a year earlier. Against the prior quarter it is down 84.7%.
Not reported for Q3 2026.
Not reported for Q3 2026.
NHC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $408.0M+6.6% | $408.0M+8.8% | $381.8M+2.2% | $386.5M+4.6% | $382.7M+12.5% | $374.9M+24.7% | $373.7M+25.7% | $369.4M+22.7% |
| SG&A Expenses | $8.7M+7.4% | $8.7M-0.9% | $5.8M-11.9% | N/A | $8.1M+29.1% | $8.8M+22.1% | $6.6M+7.6% | N/A |
| Operating Income | $40.6M+33.8% | $48.9M+43.5% | $32.3M+4.8% | $33.1M+14.5% | $30.4M+33.3% | $34.1M+51.4% | $30.8M+96.3% | $28.9M+41.4% |
| EBITDA | $55.2M+32.9% | $60.1M+33.3% | $43.9M+5.1% | $44.9M+11.2% | $41.5M+24.3% | $45.1M+41.6% | $41.7M+59.0% | $40.4M+25.3% |
| Interest Expense | $7.0M+380.2% | $13K-99.3% | $269K-87.2% | $816K-65.2% | $1.5M-16.4% | $2.0Mn/m | $2.1M+4478.3% | $2.3M+4091.1% |
| Income Tax | $5.5M-59.0% | $13.5M+67.3% | $8.7M-23.8% | $6.9M+24682.1% | $13.4M-12.6% | $8.1M-15.2% | $11.4M+20.8% | $28K-99.7% |
| Net Income | $13.6M-65.2% | $40.3M+70.0% | $35.9M+11.3% | $24.8M+308.6% | $39.2M-8.3% | $23.7M-11.6% | $32.2M+22.9% | $6.1M-78.6% |
| EPS (Basic) | $0.87-65.6% | $2.58+68.6% | $2.31+10.5% | $1.61+312.8% | $2.53-9.0% | $1.53-12.1% | $2.09+22.2% | $0.39-78.9% |
| EPS (Diluted) | $0.85-66.0% | $2.54+67.1% | $2.27+9.7% | $1.57+313.2% | $2.50-8.4% | $1.52-12.1% | $2.07+22.5% | $0.38-79.3% |
| Diluted Shares (Avg) | 16M+1.9% | 16M+1.7% | 16M+1.3% | N/A | 16M0.0% | 16M+0.3% | 16M+0.5% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
NHC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1B+31.6% | $1.5B-1.6% | $1.5B-1.6% | $1.5B+0.1% | $1.6B+0.6% | $1.6B+16.6% | $1.5B+17.4% | $1.5B+16.3% |
| Current Assets | $419.8M-14.9% | $439.6M-5.1% | $465.6M+2.3% | $461.8M+8.8% | $493.5M+10.7% | $463.2M+3.4% | $455.2M+9.0% | $424.4M+4.5% |
| Cash & Equivalents | $66.8M-48.9% | $39.2M-64.7% | $85.5M-5.4% | $92.8M+21.9% | $130.6M+54.0% | $111.0M-18.5% | $90.4M-3.8% | $76.1M-28.9% |
| Inventory | $8.7M+10.4% | $8.5M+8.2% | $9.2M+13.3% | $7.8M-13.8% | $7.8M+0.1% | $7.9M+19.0% | $8.1M+19.5% | $9.0M+22.4% |
| Accounts Receivable | $129.7M-2.0% | $137.7M-3.1% | $137.7M-2.8% | $139.0M+2.7% | $132.4M+2.8% | $142.1M+29.9% | $141.7M+12.8% | $135.3M+24.7% |
| Goodwill | $170.5M0.0% | $170.5M0.0% | $170.5M0.0% | $170.5M0.0% | $170.5M+0.5% | $170.5M+1.3% | $170.5M+1.3% | $170.5M+1.3% |
| Total Liabilities | $937.0M+82.3% | $408.9M-23.8% | $427.5M-21.0% | $451.9M-16.5% | $513.9M-10.8% | $536.8M+37.0% | $540.8M+37.6% | $541.3M+35.2% |
| Current Liabilities | $283.9M+0.6% | $236.1M-12.1% | $250.8M+4.8% | $253.6M+8.0% | $282.4M+13.9% | $268.7M+23.9% | $239.2M+15.9% | $234.8M+9.5% |
| Non-Current Liabilities | $653.1M+182.0% | $172.8M-35.6% | $176.7M-41.4% | $198.3M-35.3% | $231.6M-29.4% | $268.1M+53.3% | $301.6M+61.6% | $306.5M+64.9% |
| Long-Term Debt | $478.3M+628.9% | $0-100.0% | $0-100.0% | $32.5M-74.9% | $65.6M-49.3% | $102.5M | $126.5M | $129.5Mn/m |
| Total Equity | $1.1B+6.8% | $1.1B+9.8% | $1.1B+8.6% | $1.1B+9.0% | $1.1B+7.1% | $1.0B+8.0% | $1.0B+8.7% | $980.2M+7.9% |
| Retained Earnings | $891.8M+9.0% | $888.7M+12.7% | $858.9M+10.8% | $833.0M+10.7% | $818.1M+8.3% | $788.8M+9.2% | $775.0M+10.0% | $752.2M+9.4% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
NHC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $99.2M+49.8% | $43.3M-31.1% | $62.5M+59.3% | $16.8M+31.4% | $66.2M+93.5% | $62.8M+24.0% | $39.3M+307.0% | $12.8M-50.3% |
| Depreciation & Amortization | $14.6M+30.6% | $11.2M+1.4% | $11.6M+5.8% | $11.8M+2.9% | $11.2M+5.1% | $11.0M+18.0% | $11.0M+3.7% | $11.4M-2.8% |
| Stock-Based Compensation | N/A | N/A | $1.3M+24.6% | N/A | N/A | N/A | $1.0M+29.5% | N/A |
| Capital Expenditures | N/A | $12.5M+22.8% | $9.6M+57.1% | $10.4M+27.5% | $9.7M+71.6% | $10.2M+30.3% | $6.1M+3.1% | $8.2M-5.2% |
| Free Cash Flow | N/A | $30.7M-41.6% | $52.9M+59.7% | $6.4M+38.4% | $56.5M+97.9% | $52.6M+22.9% | $33.1M+797.3% | $4.6M-73.0% |
| Investing Cash Flow | -$556.9M-28254.2% | -$87.7Mn/m | -$13.9Mn/m | -$12.9Mn/m | $2.0Mn/m | -$15.6M-1193.3% | -$7.3Mn/m | -$11.6Mn/m |
| Financing Cash Flow | $491.8Mn/m | -$9.7Mn/m | -$54.5Mn/m | -$43.2Mn/m | -$47.0M-133.7% | -$33.0Mn/m | -$12.7Mn/m | -$19.3Mn/m |
| Dividends Paid | $10.5M+5.8% | $10.0M+5.9% | $9.9M+5.5% | $9.9M+5.4% | $9.9M+5.4% | $9.4M+3.8% | $9.4M+4.1% | $9.4M+4.2% |
| Share Buybacks | $1.1M-65.1% | $7.2M+55.3% | $16.3M+847.8% | $5.2Mn/m | $3.2M+51.5% | $4.7M+210.4% | $1.7M-82.6% | $0n/m |
NHC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0%+2.0pp | 12.0%+2.9pp | 8.5%+0.2pp | 8.6%+0.7pp | 7.9%+1.2pp | 9.1%+1.6pp | 8.2%+3.0pp | 7.8%+1.0pp |
| Net Margin | 3.3%-6.9pp | 9.9%+3.6pp | 9.4%+0.8pp | 6.4%+4.8pp | 10.3%-2.3pp | 6.3%-2.6pp | 8.6%-0.2pp | 1.7%-7.8pp |
| Return on Equity | 1.2%-2.5pp | 3.6%+1.3pp | 3.3%+0.1pp | 2.3%+1.7pp | 3.7%-0.6pp | 2.3%-0.5pp | 3.2%+0.4pp | 0.6%-2.5pp |
| Return on Assets | 0.7%-1.8pp | 2.6%+1.1pp | 2.4%+0.3pp | 1.6%+1.2pp | 2.5%-0.2pp | 1.5%-0.5pp | 2.1%+0.1pp | 0.4%-1.8pp |
| Current Ratio | 1.48-0.3x | 1.86+0.1x | 1.860.0x | 1.820.0x | 1.750.0x | 1.72-0.3x | 1.90-0.1x | 1.81-0.1x |
| Debt-to-Equity | 0.43+0.4x | 0.00-0.1x | 0.00-0.1x | 0.03-0.1x | 0.06-0.1x | 0.10 | 0.13 | 0.13+0.1x |
| Liabilities-to-Equity | 0.83+0.3x | 0.36-0.2x | 0.39-0.1x | 0.42-0.1x | 0.49-0.1x | 0.53+0.1x | 0.54+0.1x | 0.55+0.1x |
| Asset Turnover | 0.200.0x | 0.270.0x | 0.250.0x | 0.250.0x | 0.240.0x | 0.240.0x | 0.240.0x | 0.240.0x |
| FCF Margin | N/A | 7.5%-6.5pp | 13.9%+5.0pp | 1.7%+0.4pp | 14.8%+6.4pp | 14.0%-0.2pp | 8.9%+7.6pp | 1.3%-4.4pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| National Healthcare Corp. NHC | FY2025 | $1.5B | $120.0M | 7.9% | $3.0B | 65/100 |
| Surgery Partners, Inc. SGRY | FY2025 | $3.3B | -$77.9M | -2.4% | $3.5B | 54/100 |
| Guardian Pharmacy Services, Inc. GRDN | FY2025 | $1.4B | $49.2M | 3.4% | $3.0B | 52/100 |
| Acadia Healthcare Company, Inc. ACHC | FY2025 | $3.3B | -$1.1B | -33.3% | $3.2B | 27/100 |
| Brookdale Senior Living, Inc. BKD | FY2025 | $3.2B | -$262.7M | -8.2% | $2.1B | 24/100 |
| Aveanna Healthcare Holdings Inc. AVAH | FY2026 | $2.4B | $225.0M | 9.3% | $2.4B | 44/100 |
Where National Healthcare Corp. Ranks
Frequently Asked Questions
National Healthcare Corp. (NHC) reported $1.5B in total revenue for fiscal year 2025. This represents a 16.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
National Healthcare Corp. (NHC) revenue grew by 16.1% year-over-year, from $1.3B to $1.5B in fiscal year 2025.
Yes, National Healthcare Corp. (NHC) reported a net income of $120.0M in fiscal year 2025, with a net profit margin of 7.9%.
National Healthcare Corp. (NHC) had EBITDA of $173.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, National Healthcare Corp. (NHC) had $92.8M in cash and equivalents against $32.5M in long-term debt.
National Healthcare Corp. (NHC) had an operating margin of 8.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
National Healthcare Corp. (NHC) had a net profit margin of 7.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, National Healthcare Corp. (NHC) paid $2.53 per share in dividends during fiscal year 2025.
National Healthcare Corp. (NHC) has a return on equity of 11.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
National Healthcare Corp. (NHC) generated $148.6M in free cash flow during fiscal year 2025. This represents a 86.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
National Healthcare Corp. (NHC) generated $185.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
National Healthcare Corp. (NHC) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.
National Healthcare Corp. (NHC) invested $36.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
National Healthcare Corp. (NHC) had a current ratio of 1.82 as of fiscal year 2025, which is generally considered healthy.
National Healthcare Corp. (NHC) had a debt-to-equity ratio of 0.03 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
National Healthcare Corp. (NHC) had a liabilities-to-equity ratio of 0.42 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
National Healthcare Corp. (NHC) had a return on assets of 7.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
National Healthcare Corp. (NHC) trades at 26.1x earnings, its market capitalization divided by $114.7M net income, trailing 12 months to September 30, 2026. The market capitalization is $3.0B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
National Healthcare Corp. (NHC) trades at 1.9x sales, its market capitalization divided by $1.6B revenue, trailing 12 months to September 30, 2026. The market capitalization is $3.0B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
National Healthcare Corp. (NHC) has an Altman Z-Score of 6.17, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
National Healthcare Corp. (NHC) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
National Healthcare Corp. (NHC) has an earnings quality ratio of 1.54x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
National Healthcare Corp. (NHC) has an interest coverage ratio of 20.15x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
National Healthcare Corp. (NHC) scores 65 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.